Johnson & Johnson's agreement with the Trump administration enables patients to access drugs at a comparable price to other ...

Aragen's new cell line development and early manufacturing platform, CHOMax, can cut timelines to approximately 10 months.

aims to advance oncology research by integrating computational design, medicinal chemistry, biology, medical science and ...

Codexis Inc. and Axolabs have entered into an agreement under which Axolabs will evaluate Codexis’ ECO Synthesis ...

AstraZeneca has named Rick R. Suarez as Senior Vice President, U.S. President and Head of the U.S. Biopharmaceuticals ...

Patient access to innovative new therapies requires us to reimagine the supply chain and how it integrates advanced ...

Viking Therapeutics announced its new Chief Commercial Officer, Neil Aubuchon, on Jan. 7, 2026. Viking is a clinical-stage ...

Eli Lilly and Company has entered a definitive agreement to acquire Ventyx Biosciences Inc., a San Diego-based clinical-stage ...

Sharp Sterile Manufacturing is investing $28 million to expand its site in Lee, Massachusetts, which offers a range of ...

Magali Haas, MD, PhD, founded Cohen Veterans Bioscience and worked at Johnson & Johnson before becoming Psilera's new Chief ...

Rentschler Biopharma, a global CDMO for biopharmaceuticals, and VarmX, a biotech company developing direct oral ...

Halozyme Therapeutics Inc. has entered into a global collaboration and exclusive license agreement with Takeda.